Shift To Biosimilars, $5 Bn Nutraceutical Boom: India`s Pharma Sector Prepares For Next BIG Leap

From reducing reliance on Chinese APIs to expanding innovation in biologics and next-generation therapies like GLP-1 agonists for obesity and diabetes, the sector is moving beyond its generics-driven legacy into a future powered by scientific capability, self-reliance, and global market leadership.